Back

The incidence and clinical features of anticancer therapy induced atrial fibrillation in patients with breast cancer without previously established cardiac disorder

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Atrial fibrillation and concomitant medical conditions Prevalence and Incidence of Atrial Fibrillation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Abdulla Arslan

Baskent University Istanbul Hospital, Istanbul (Turkiye)

5 More presentations in this session

Presentation thumbnail
Associations between pregnancy complications and incident cardiovascular disease: a nationwide data linkage study in Wales
Mr T. Al Bahhawi (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Baseline characteristics of patients with atrial fibrillation and cancer enrolled in the BLITZ-AF Cancer registry
Doctor P. Ameri (Genova, IT)
Abstract Slides
Presentation thumbnail
Clinical characteristics and outcomes of atrial fibrillation patients with peripheral artery disease: The Fushimi AF Registry.
Doctor N. Masunaga (Kyoto, JP)
Abstract Slides
Presentation thumbnail
New-onset atrial fibrillation in patients with community-acquired pneumonia: a systematic review and meta-analysis
Doctor B. Corica (Modena, IT)
Abstract Slides
Presentation thumbnail
Risk of arterial thromboembolism in patients with concomitant atrial fibrillation and cancer: a systematic review and meta-analysis
Doctor A. Kartas (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
Atrial fibrillation and concomitant medical conditions

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources